Clinical Trial Update: The Feasibility of Using the PulsePoint to Facilitate Overdose Education and Naloxone Distribution [NA]

View source ↗

Summary

This clinical trial update reports on the feasibility of using the PulsePoint platform to facilitate overdose education and naloxone distribution; the study is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Overdose
• Opioid Use Disorder

Drugs mentioned

• Narcan (Naloxone) (naloxone)

Snippet

Sponsor: Indiana University | Conditions: Carrying Naloxone/Narcan on Their Person or in Their Vehicle, Being Trained to Respond to an Opioid Overdose | NA | Status: ENROLLING_BY_INVITATION